PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Hybrid CDSS Flags Anticoagulant Prescribing Errors With No Misses

apixabandabigatranedoxabanrivaroxabanwarfarinlow-molecular-weight heparinDOACanticoagulationclinical decision support systemmachine learningCatBoostmedication safetyprescribing errorsdrug-drug interactionspharmacist reviewexternal validation Anticoagulation / Hematology

Background Information

Hybrid CDSS boosts anticoagulant prescription safety with smart alerts.

Anticoagulants carry a high risk of bleeding errors, making effective prescription review vital to patient safety. The hybrid CDSS generated clinically relevant alerts with strong discrimination (AUC 0.871 to 0.963), and up to 57.1% required pharmacist intervention. While promising, validation period and sample limitations suggest cautious interpretation of the CDSS's broader applicability. This hybrid CDSS might enhance pharmacist-led anticoagulant review by prioritizing clinically relevant alerts.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Jeong J, Heo KN, Kim AJ, Baek JH, Jo YH, Kim S, Jo M, Ah YM, Han JM, Choi SW, Song J, Min S, Lee JY

Citation: Jeong J, Heo KN, Kim AJ, et al. A Hybrid Rule-Based and Machine Learning-Based Clinical Decision Support System to Support Prescription Review: Development and External Validation Study. Journal of medical Internet research. 2026;28:e101202. doi:10.2196/101202

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.